Dapagliflozin plus metformin improved glycemic control, weight loss

Links shared publicly online about this topic.

  • 1,065
    total visits

Dapagliflozin plus metformin improved glycemic control, weight loss

endocrinetoday.com

ADA 70th Scientific Sessions ORLANDO — Dapagliflozin, an investigational selective sodium-glucose cotransporter-2 inhibitor, improved H

View full resource at endocrinetoday.com

Tags: Diabetes Type 2 Medication, Diabetes Medication, Weight Loss, Glucophage

  • Share

Most Recently Shared on March 9, 2011 at 4:35 pm By:

FiercePharma FiercePharma

RT @eyeonfda: RT @hmsilverman: FDA accepts AZ application for dapagliflozin, a unique new T2 diabetes med. http://j.mp/fltz3G

2 years ago...

Also Shared By:

Endocrine Today Endocrine Today

eyeonfda eyeonfda

Advertisement